Celgene Corporation and Agios Pharmaceuticals, Inc. Company Profile

00:05 EDT 17th March 2018 | BioPortfolio

News Articles [1230 Associated News Articles listed on BioPortfolio]

Agios' AML therapy accepted under priority review by FDA

Agios Pharmaceuticals' new-drug application for ivosidenib, which is being developed as a treatment for patients with isocitr -More- 

Celgene im Übernahmefieber: Darum passt die BB-Biotech-Beteiligung Agios ins Beuteschema

Mit gleich zwei größeren Akquisitionen hat Celgene vor Kurzem die eigene Pipeline gestärkt. Doch der Übernahmehunger der Biotech-Firma ist keineswegs gestillt: Wie der Finanzvorstand im Rahmen der...

Agios seeks FDA approval for leukemia candidate ivosidenib

Agios Pharmaceuticals filed a new-drug application for its experimental drug ivosidenib, or AG-120, as a treatment for patien -More- 

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

STAT Plus: Agios unveils new leukemia drug data to support end-of-year FDA approval filing

Agios Pharmaceuticals gave a peek at some data on its second leukemia drug.

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Ag...

Cancer Deal, PTV News: Apr 16, 2010

Celgene and Agios in quarter billion dollar cancer metabolism pact

Agios nets $449mm through public offering

Agios Pharmaceuticals Inc. (therapies for cancer and rare genetic diseases) netted $449mm through a public offering of 7.1mm common shares at $67. Proceeds will support the company's pipeline activiti...

PubMed Articles [119 Associated PubMed Articles listed on BioPortfolio]

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [217 Associated Clinical Trials listed on BioPortfolio]

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell therapy participating in a p...

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Multi-center, survival data collection in subjects previously enrolled in Celgene Protocol CC-5013-MDS-003.

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1492 Associated Companies listed on BioPortfolio]

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has ...

Celgene Corporation and Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadersh...

Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To suppor...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

More Information about "Celgene Corporation and Agios Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Celgene Corporation and Agios Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Celgene Corporation and Agios Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Celgene Corporation and Agios Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celgene Corporation and Agios Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Celgene Corporation and Agios Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record